Skip to main content
. Author manuscript; available in PMC: 2014 Feb 4.
Published in final edited form as: Mol Pharm. 2013 Jan 14;10(2):709–716. doi: 10.1021/mp300507r

Figure 4.

Figure 4

Quantitative analysis of the PET data. (A) Time-activity curves of the liver, 4T1 tumor, blood, kidney, and muscle upon intravenous injection of 64Cu-NOTA-TRC105-F(ab')2. (B) Time-activity curves of the liver, 4T1 tumor, blood, kidney, and muscle upon intravenous injection of 64Cu-NOTA-TRC105-F(ab')2, after a blocking dose of TRC105. (C) Comparison of tracer uptake in the 4T1 tumors between the two groups. n = 4; *, P < 0.05.